Page 867 - Saunders Comprehensive Review For NCLEX-RN
P. 867

10. Have emergency equipment readily accessible.
                                           11. Document the dose of the medication and the time the
                                                medication was started, increased, maintained, and
                                                discontinued; document the client’s response.
                                           12. Keep the client and family informed of the client’s
                                                progress.
                                           13. Calculating an oxytocin drip (Box 28-3)



                                                    Priority Nursing Actions


                                                Hypertonic Contractions or a Nonreassuring Fetal Heart Rate during
                                                Oxytocin Infusion
                                                    1. Stop the oxytocin infusion.
                                                    2. Turn the client on her side, stay with the client, and ask another
                                                       nurse to contact the obstetrician (OB).
                                                    3. Increase the flow rate of the intravenous (IV) solution that does
                                                       not contain the oxytocin.
                                                    4. Administer oxygen, 8 to 10 L/minute, by snug face mask.
                                                    5. Assess maternal vital signs; fetal heart rate and patterns; and
                                                       frequency, duration, and force of contractions.
                                                    6. Document the event, actions taken, and the response.

                                                Reference

                                                    Lowdermilk et al. (2016), p. 784.

                    VII. Medications Used to Manage Postpartum Hemorrhage (Box 28-4)
                                A. Ergot alkaloid
                                             1. Description
                                                             a. Methylergonovine maleate is an ergot
                                                                alkaloid.
                                                             b. Directly stimulates uterine muscle,
                                                                increases the force and frequency of
                                                                contractions, and produces a firm
                                                                tetanic contraction of the uterus

                                                                    c. Can produce arterial

                                                                vasoconstriction and vasospasm of the
                                                                coronary arteries
                                                             d. An ergot alkaloid is administered
                                                                postpartum and is not administered
                                                                before the birth of the placenta.
                                             2. Uses
                                                             a. Postpartum hemorrhage
                                                             b. Postabortal hemorrhage resulting from
                                                                atony or involution
                                             3. Adverse effects and contraindications
                                                                    a. Can cause nausea, uterine





                                                          867
   862   863   864   865   866   867   868   869   870   871   872